-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Turnstone Biologics Corp. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2022 to Q3 2024.
- Turnstone Biologics Corp. Operating Income (Loss) for the quarter ending September 30, 2024 was -$18.4M, a 2.97% increase year-over-year.
- Turnstone Biologics Corp. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$79M.
- Turnstone Biologics Corp. annual Operating Income (Loss) for 2023 was -$59M, a 86.7% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)